Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research and development unit to manufacture high-end biosimilars and biopharmaceuticals. The company... Full Story
Hyderabad-based generic pharmaceutical company Hetero Group has bought around 600 acres of land for over Rs. 350 crore from a US-based fund,... Full Story
Shanghai Fosun Pharmaceutical (Group) Co. Ltd, the Hong Kong-listed company controlled by billionaire Guo Guangchang, said it had submitted a... Full Story
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2022
Premium Projects Database
Project Marketing Assistance
EPXonline.com 
